Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
GSE1 antisense RNA 1 (GSE1-AS1) is a long noncoding antisense RNA transcribed from the genomic region opposite to the GSE1 gene. Like other antisense RNAs, it is presumed to regulate the expression of its sense gene (GSE1) or other nearby genes via various mechanisms, including modulating chromatin structure, affecting transcription, or altering mRNA stability[1][2][5]. While antisense RNAs as a class can play important roles in development, disease, and especially in cancer, there is currently no direct evidence or detailed functional characterization of GSE1-AS1 in the literature from the search results provided. The molecule is not currently recognized as a drug target, receptor, transporter, or enzyme, and no specific disease-association or druggability information is available for GSE1-AS1. It belongs to the broader category of long noncoding RNAs, specifically those acting in an antisense orientation to protein-coding genes.
None established for GSE1-AS1 specifically; in general, antisense lncRNAs modulate gene expression by binding to sense mRNAs or altering chromatin state[1][2][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on GSE1 antisense RNA 1 (GSE1-AS1).